Pfizer Inc

Insider Reports History

Entity: Company
Location: 66 Hudson Boulevard East, New York, NY
Signature: Pfizer Inc. by /s/ Susan Grant, Assistant Secretary
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pfizer Inc:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Oric Pharmaceuticals, Inc.	10%+ Owner	Common Stock	5.38M	$46.2M	$8.59	Dec 23, 2022	Direct
Pyxis Oncology, Inc.	10%+ Owner	Common Stock, $0.001 par value per share	5.95M	$16.4M	$2.76	Mar 17, 2023	Direct
Pyxis Oncology, Inc.	10%+ Owner	Common Stock, $0.001 par value per share	1.08M	$2.98M	$2.76	Mar 17, 2023	By Pfizer Ventures (US) LLC
Cerevel Therapeutics Holdings, Inc.	Former 10% Owner	Common Stock	0	$0	$45.00	Aug 1, 2024	Direct
Zura Bio Ltd	10%+ Owner	Class A Ordinary Shares, $0.0001 par value	2.97M			Mar 20, 2023	Direct

Showing 1 to 5 of 5 entries

Insider Reports Filed by Pfizer Inc

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
CERE	Cerevel Therapeutics Holdings, Inc.	Aug 1, 2024	1	-$1.23B	4	Aug 5, 2024	Former 10% Owner
ZURA	Zura Bio Ltd	Mar 20, 2023	0	$0	3	Mar 30, 2023	10%+ Owner
PYXS	Pyxis Oncology, Inc.	Mar 17, 2023	1	$5M	4/A	Mar 23, 2023	10%+ Owner
ORIC	Oric Pharmaceuticals, Inc.	Dec 23, 2022	0	$0	3	Dec 29, 2022	10%+ Owner
PYXS	Pyxis Oncology, Inc.	Oct 6, 2022	0	$0	3	Oct 13, 2022	10%+ Owner